Tasquinimod (Standard)
Tasquinimod (Standard) is the analytical standard of Tasquinimod. This product is intended for research and analytical applications. Tasquinimod is an oral antiangiogenic agent, which has the potential for castration-resistant prostate cancer treatment. Tasquinimod binds to the regulatory Zn2+ binding domain of HDAC4 with Kd of 10-30 nM. Tasquinimod also is a S100A9 inhibitor[1][2][3].
Product Specifications
CAS Number
254964-60-8
Product Name Alternative
ABR-215050 (Standard)
UNSPSC
12352005
Target
HDAC; Reference Standards
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; Others
Field of Research
Cancer
Smiles
O=C(C1=C(O)C2=C(N(C)C1=O)C=CC=C2OC)N(C)C3=CC=C(C(F)(F)F)C=C3
Molecular Formula
C20H17F3N2O4
Molecular Weight
406.36
References & Citations
[1]Isaacs JT, et al. Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment. Cancer Res. 2013 Feb 15;73 (4) :1386-99.|[2]Isaacs JT, et al. Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment. Oncotarget. 2014 Sep 30;5 (18) :8093-106.|[3]Olsson A, et al. Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors. Mol Cancer. 2010 May 17;9:107.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ICH1139-50mg 50 mg
Anti-Mouse PD-L2 (TY25) In Vivo Antibody - Low Endotoxin
Sign In for Pricing
View Details 
BNC051331-1ML 1x 1 mL
Isotype Control, Mouse IgG1 Kappa (IGG1/1331), CF405M Conjugate, 0.1 mg/mL
Sign In for Pricing
View Details 
BNC040640-100 1x 100 µL
CD34 (QBEnd/10), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details